Symbiotec Pharmalab is a pharmaceutical and biotechnology company with over 30 years of experience. It mainly manufactures Corticosteroid and Steroidal Hormone APIs, which are important ingredients used to make medicines.
Market Dashboard
Symbiotec Pharmalab
ListedMainboardBook built Issue
Issue Price
₹938 to ₹988Face Value
₹2 Per Equity ShareIssue Size
₹1,757 Cr.Listing On
BSENSE
Live
Allotment Available
Check your individual allotment on the official registrar portal.
Grey Market
₹185
+18.72% Est. Listing Premium
Est. Listing Price₹1173
Updated: 31 Aug 2026, 23:28
About Symbiotec Pharmalab IPO
Financial Health
Live Subscriptions
Updated: 27 Aug 2026, 22:15Tracking
Frequently Asked Questions
The public subscription window officially opens on 24 August 2026 and concludes at 5:00 PM IST on 27 August 2026.
As of the latest market information, the GMP is ₹185, indicating a 18.72% estimated listing premium. GMP is an unofficial market indicator and can change rapidly.
Shares are offered at ₹938 to ₹988. Retail investors must bid for at least 15 shares, requiring a block investment of ₹14,820.
The allotment has been detected as available in the MUFG Intime India Pvt. Ltd. system. You can use the official registrar link on this page to check your individual status. Shares are scheduled to debut on the exchanges on 01 September 2026.
The registrar for this IPO is MUFG Intime India Pvt. Ltd..
The issue size for Symbiotec Pharmalab is ₹1,757 Cr..
The current status of the Symbiotec Pharmalab IPO is Listed. This status is determined from the issue and listing timeline using Indian Standard Time.
No. GMP is unofficial and can move significantly before listing. The actual listing price may differ from the GMP-based estimate.